Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
| 2022-06-07 Sale | 2022-06-08 4:03 pm | FATE THERAPEUTICS INC | FATE | Agarwal Shefali Director | 841 | $21.89 | $18,409 | 1,840 (Direct) | View |
| 2022-06-03 Sale | 2022-06-06 4:49 pm | FATE THERAPEUTICS INC | FATE | MENDLEIN JOHN Director | 1,364 | $22.79 | $31,086 | 158,091 (Direct) | View |
| 2022-06-03 Sale | 2022-06-06 4:48 pm | FATE THERAPEUTICS INC | FATE | Jooss Karin Director | 1,483 | $22.82 | $33,842 | 1,198 (Direct) | View |
| 2022-06-03 Sale | 2022-06-06 4:45 pm | FATE THERAPEUTICS INC | FATE | HERSHBERG ROBERT Director | 672 | $22.75 | $15,288 | 2,009 (Direct) | View |
| 2022-06-03 Sale | 2022-06-06 4:43 pm | FATE THERAPEUTICS INC | FATE | COUGHLIN TIMOTHY Director | 1,439 | $22.81 | $32,824 | 57,632 (Direct) | View |
| 2022-06-03 Sale | 2022-06-06 4:40 pm | FATE THERAPEUTICS INC | FATE | Agarwal Shefali Director | 807 | $22.8 | $18,400 | 1,874 (Direct) | View |
| 2022-06-01 Sale | 2022-06-02 4:04 pm | FATE THERAPEUTICS INC | FATE | TAHL CINDY General Counsel and Secretary | 25,000 | $22.96 | $574,000 | 243,361 (Direct) | View |
| 2022-04-21 Sale | 2022-04-25 4:11 pm | FATE THERAPEUTICS INC | FATE | Wolchko J Scott CEO | 40,000 | $34.89 | $1,395,792 | 514,038 (Direct) | View |
| 2022-04-19 Sale | 2022-04-21 4:04 pm | FATE THERAPEUTICS INC | FATE | Chu Yu-Waye Chief Medical Officer | 4,062 | $35.37 | $143,673 | 151,033 (Direct) | View |
| 2022-04-01 Sale | 2022-04-04 5:01 pm | FATE THERAPEUTICS INC | FATE | TAHL CINDY General Counsel and Secretary | 25,000 | $38.85 | $971,250 | 276,556 (Direct) | View |
| 2022-03-14 Sale | 2022-03-15 4:27 pm | FATE THERAPEUTICS INC | FATE | Valamehr Bahram Chief R & D Officer | 25,000 | $31.07 | $776,733 | 215,990 (Direct) | View |
| 2022-03-10 Sale | 2022-03-11 4:58 pm | FATE THERAPEUTICS INC | FATE | MENDLEIN JOHN Director | 31,562 | $35.02 | $1,105,200 | 159,455 (Direct) | View |
| 2022-01-20 Sale | 2022-01-24 4:36 pm | FATE THERAPEUTICS INC | FATE | Wolchko J Scott CEO | 40,000 | $39.66 | $1,586,500 | 540,992 (Direct) | View |
| 2022-01-11 Sale | 2022-01-13 4:09 pm | FATE THERAPEUTICS INC | FATE | Wolchko J Scott CEO | 14,566 | $48.68 | $709,027 | 431,546 (Direct) | View |
| 2022-01-11 Sale | 2022-01-13 4:08 pm | FATE THERAPEUTICS INC | FATE | TAHL CINDY General Counsel and Secretary | 5,419 | $48.53 | $262,975 | 155,849 (Direct) | View |
| 2022-01-11 Sale | 2022-01-13 4:07 pm | FATE THERAPEUTICS INC | FATE | Valamehr Bahram Chief R & D Officer | 4,570 | $48.5 | $221,655 | 146,532 (Direct) | View |
| 2022-01-11 Sale | 2022-01-13 4:06 pm | FATE THERAPEUTICS INC | FATE | Dulac Edward J III CFO | 1,770 | $48.45 | $85,757 | 108,634 (Direct) | View |
| 2022-01-11 Sale | 2022-01-13 4:05 pm | FATE THERAPEUTICS INC | FATE | Chu Yu-Waye VP | 3,965 | $48.51 | $192,340 | 121,793 (Direct) | View |
| 2022-01-10 Sale | 2022-01-12 4:07 pm | FATE THERAPEUTICS INC | FATE | Wolchko J Scott CEO | 34,156 | $46.86 | $1,600,534 | 446,112 (Direct) | View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2022-06-27 Option Award | 2022-06-29 5:02 pm | N/A 2032-06-27 | FATE THERAPEUTICS INC | FATE | Powl Brian T. Chief Commercial Officer | 115,000 | $0 | 115,000 (Direct) | View |
| 2022-06-09 Option Award | 2022-06-13 9:31 pm | N/A 2032-06-09 | FATE THERAPEUTICS INC | FATE | Redmile Group LLC Green Jeremy Director 10% Owner | 20,543 | $0 | 12,980,446 (Indirect) | View |
| 2022-06-09 Option Award | 2022-06-13 9:30 pm | N/A 2032-06-09 | FATE THERAPEUTICS INC | FATE | Lee Michael Stewart Director | 20,543 | $0 | 23,224 (Direct) | View |
| 2022-06-09 Option Award | 2022-06-13 4:44 pm | N/A 2032-06-09 | FATE THERAPEUTICS INC | FATE | Xu Yuan Director | 20,543 | $0 | 25,287 (Direct) | View |
| 2022-06-09 Option Award | 2022-06-13 4:43 pm | N/A 2032-06-09 | FATE THERAPEUTICS INC | FATE | RASTETTER WILLIAM H Director | 20,543 | $0 | 629,317 (Direct) | View |
| 2022-06-09 Option Award | 2022-06-13 4:42 pm | N/A 2032-06-09 | FATE THERAPEUTICS INC | FATE | MENDLEIN JOHN Director | 20,543 | $0 | 178,634 (Direct) | View |
| 2022-06-09 Option Award | 2022-06-13 4:41 pm | N/A 2032-06-09 | FATE THERAPEUTICS INC | FATE | Jooss Karin Director | 20,543 | $0 | 21,741 (Direct) | View |
| 2022-06-09 Option Award | 2022-06-13 4:41 pm | N/A 2032-06-09 | FATE THERAPEUTICS INC | FATE | HERSHBERG ROBERT Director | 20,543 | $0 | 22,552 (Direct) | View |
| 2022-06-09 Option Award | 2022-06-13 4:40 pm | N/A 2032-06-09 | FATE THERAPEUTICS INC | FATE | EPSTEIN ROBERT S Director | 20,543 | $0 | 23,224 (Direct) | View |
| 2022-06-09 Option Award | 2022-06-13 4:39 pm | N/A 2032-06-09 | FATE THERAPEUTICS INC | FATE | COUGHLIN TIMOTHY Director | 20,543 | $0 | 78,175 (Direct) | View |
| 2022-06-09 Option Award | 2022-06-13 4:38 pm | N/A 2032-06-09 | FATE THERAPEUTICS INC | FATE | Agarwal Shefali Director | 20,543 | $0 | 22,383 (Direct) | View |
| 2022-06-01 Exercise | 2022-06-02 4:04 pm | N/A 2028-01-16 | FATE THERAPEUTICS INC | FATE | TAHL CINDY General Counsel and Secretary | 25,000 | $0 | 243,361 (Direct) | View |
| 2022-06-01 Exercise | 2022-06-02 4:04 pm | N/A N/A | FATE THERAPEUTICS INC | FATE | TAHL CINDY General Counsel and Secretary | 25,000 | $6.55 | 243,361 (Direct) | View |
| 2022-04-21 Exercise | 2022-04-25 4:11 pm | N/A 2027-01-03 | FATE THERAPEUTICS INC | FATE | Wolchko J Scott CEO | 40,000 | $2.7 | 514,038 (Direct) | View |
| 2022-04-01 Exercise | 2022-04-04 5:01 pm | N/A 2025-01-05 | FATE THERAPEUTICS INC | FATE | TAHL CINDY General Counsel and Secretary | 25,000 | $0 | 276,556 (Direct) | View |
| 2022-04-01 Exercise | 2022-04-04 5:01 pm | N/A N/A | FATE THERAPEUTICS INC | FATE | TAHL CINDY General Counsel and Secretary | 5,567 | $6.55 | 276,556 (Direct) | View |
| 2022-04-01 Exercise | 2022-04-04 5:01 pm | N/A N/A | FATE THERAPEUTICS INC | FATE | TAHL CINDY General Counsel and Secretary | 19,433 | $4.84 | 276,556 (Direct) | View |
| 2022-03-14 Exercise | 2022-03-15 4:27 pm | N/A 2027-01-04 | FATE THERAPEUTICS INC | FATE | Valamehr Bahram Chief R & D Officer | 25,000 | $0 | 215,990 (Direct) | View |
| 2022-03-14 Exercise | 2022-03-15 4:27 pm | N/A N/A | FATE THERAPEUTICS INC | FATE | Valamehr Bahram Chief R & D Officer | 25,000 | $2.73 | 215,990 (Direct) | View |
| 2022-03-10 Exercise | 2022-03-11 4:58 pm | N/A 2022-03-12 | FATE THERAPEUTICS INC | FATE | MENDLEIN JOHN Director | 31,562 | $0 | 159,455 (Direct) | View |
| 2022-03-10 Exercise | 2022-03-11 4:58 pm | N/A N/A | FATE THERAPEUTICS INC | FATE | MENDLEIN JOHN Director | 31,562 | $1.63 | 159,455 (Direct) | View |
| 2022-01-20(A) Exercise | 2022-02-04 5:59 pm | N/A 2026-01-11 | FATE THERAPEUTICS INC | FATE | Wolchko J Scott CEO | 40,000 | $0 | 624,038 (Direct) | View |
| 2022-01-20(A) Exercise | 2022-02-04 5:59 pm | N/A N/A | FATE THERAPEUTICS INC | FATE | Wolchko J Scott CEO | 30,000 | $2.7 | 624,038 (Direct) | View |
| 2022-01-25 Option Award | 2022-01-27 4:38 pm | N/A 2032-01-24 | FATE THERAPEUTICS INC | FATE | Valamehr Bahram See Remarks | 86,360 | $0 | 232,892 (Direct) | View |
| 2022-01-25 Option Award | 2022-01-27 4:37 pm | N/A 2032-01-24 | FATE THERAPEUTICS INC | FATE | Chu Yu-Waye Chief Medical Officer | 86,360 | $0 | 208,153 (Direct) | View |
| 2022-01-25 Option Award | 2022-01-27 4:37 pm | N/A 2032-01-24 | FATE THERAPEUTICS INC | FATE | Plavsic Mark CTO | 86,360 | $0 | 183,900 (Direct) | View |
| 2022-01-25 Option Award | 2022-01-27 4:35 pm | N/A 2032-01-24 | FATE THERAPEUTICS INC | FATE | Dulac Edward J III CFO | 86,360 | $0 | 194,994 (Direct) | View |
| 2022-01-25 Option Award | 2022-01-27 4:09 pm | N/A 2032-01-24 | FATE THERAPEUTICS INC | FATE | Wolchko J Scott CEO | 289,403 | $0 | 289,403 (Direct) | View |
| 2022-01-25 Option Award | 2022-01-27 4:06 pm | N/A 2032-01-24 | FATE THERAPEUTICS INC | FATE | TAHL CINDY See Remarks | 86,360 | $0 | 242,209 (Direct) | View |
| 2021-07-01(A) Exercise | 2022-01-27 4:04 pm | N/A 2028-01-16 | FATE THERAPEUTICS INC | FATE | TAHL CINDY General Counsel and Secretary | 15,383 | $0 | 184,777 (Direct) | View |
| 2022-01-20 Exercise | 2022-01-24 4:36 pm | N/A 2027-01-03 | FATE THERAPEUTICS INC | FATE | Wolchko J Scott CEO | 30,000 | $2.73 | 540,992 (Direct) | View |
| 2022-01-20 Exercise | 2022-01-24 4:36 pm | N/A 2026-01-11 | FATE THERAPEUTICS INC | FATE | Wolchko J Scott CEO | 10,000 | $2.7 | 540,992 (Direct) | View |